6 April 2023 in Nature Genetics
Anti-PD-1/PD-L1 agents have transformed the treatment landscape of advanced non-small cell lung cancer (NSCLC). To expand our understanding of the molecular features underlying response to checkpoint inhibitors in NSCLC, we describe here the first joint analysis of the Stand Up To Cancer-Mark Foundation cohort, a resource of whole exome and/or RNA sequencing from 393 patients with NSCLC treated with anti-PD-(L)1 therapy, along with matched clinical response annotation. We identify a number of associations between molecular features and outcome, including (1) favorable (for example, ATM altered) and unfavorable (for example, TERT amplified) genomic subgroups, (2) a prominent association between expression of inducible components of the immunoproteasome and response and (3) a dedifferentiated tumor-intrinsic subtype with enhanced response to checkpoint blockade. Taken together, results from this cohort demonstrate the complexity of biological determinants underlying immunotherapy outcomes and reinforce the discovery potential of integrative analysis within large, well-curated, cancer-specific cohorts.
23 May 2022 in Journal of Experimental Medicine
Transcription factors ThPOK and Runx3 regulate the differentiation of “helper” CD4+ and “cytotoxic” CD8+ T cell lineages respectively, inducing single positive (SP) T cells that enter the periphery with the expression of either the CD4 or CD8 co-receptor. Despite the expectation that these cell fates are mutually exclusive and that mature CD4+CD8+ double positive (DP) T cells are present in healthy individuals and augmented in the context of disease, yet their molecular features and pathophysiologic role are disputed. Here, we show DP T cells in murine and human tumors as a heterogenous population originating from SP T cells which re-express the opposite co-receptor and acquire features of the opposite cell type’s phenotype and function following TCR stimulation. We identified distinct clonally expanded DP T cells in human melanoma and lung cancer by scRNA sequencing and demonstrated their tumor reactivity in cytotoxicity assays. Our findings indicate that antigen stimulation induces SP T cells to differentiate into DP T cell subsets gaining in polyfunctional characteristics.
15 February 2022 in Cell Reports Medicine
Immune checkpoint blockade (CPB) improves melanoma outcomes, but many patients still do not respond. Tumor mutational burden (TMB) and tumor-infiltrating T cells are associated with response, and integrative models improve survival prediction. However, integrating immune/tumor-intrinsic features using data from a single assay (DNA/RNA) remains underexplored. Here, we analyze whole-exome and bulk RNA sequencing of tumors from new and published cohorts of 189 and 178 patients with melanoma receiving CPB, respectively. Using DNA, we calculate T cell and B cell burdens (TCB/BCB) from rearranged TCR/Ig sequences and find that patients with TMBhigh and TCBhigh or BCBhigh have improved outcomes compared to other patients. By combining pairs of immune- and tumor-expressed genes, we identify three gene pairs associated with response and survival, which validate in independent cohorts. The top model includes lymphocyte-expressed MAP4K1 and tumor-expressed TBX3. Overall, RNA or DNA-based models combining immune and tumor measures improve predictions of melanoma CPB outcomes.
9 October 2026 in bioRxiv
Genotype calling of sequencing data has improved over recent years thanks to technological and statistical breakthroughs. One such advance is the use of imputation-based genotyping methods in human genetics. For haploid and mostly non-recombining organisms, a natural equivalent is to leverage phylogenetic signal for imputation-based genotype calling. SARS-CoV-2 is one such case, and the use of improved genotyping methods in this species is particularly pertinent given the well-documented systematic problems with read alignment and assembly in rapidly evolving regions of its genome, motivating the need for statistically principled methods for genotype correction that complement existing community efforts to curate sequencing data. We present a statistical framework to combine phylogenetic prior probabilities with the information from aligned reads, and demonstrate its utility in correcting consensus calls made on short-read, viral sequencing data. We derive phylogenetically-informed posterior probabilities based on genome placement in a reference phylogeny, and read likelihoods calculated from machine-reported base quality scores. We further modify the prior at each site by estimating a maximum-likelihood scaling parameter jointly with reads at all other sites. We find that the phylogenetically-informed base calling method stays highly accurate across simulated depth and error conditions. In real datasets, the method vastly improves call rate while still maintaining similar accuracy as reference-based assembly methods. In problematic genomic regions, the phylogenetically-informed method confers both accuracy and call rate gains. Accuracy and call rate do not stratify with sequencing center and primer scheme used, suggesting broad applicability across sequencing technologies and potentially diverging sequences. Our results in real and simulated data demonstrate that phylogenetically-informed genotyping correction results in more complete sequences, achieving a higher call rate without compromising accuracy. In cases of low mean depth, sparse coverage, or difficult-to-sequence regions that may still retain a low call rate, the method improves the accuracy of genotype calls.